Skip to main content

The Health Data Security Platform for EU Developers Enterprises

Periodic Reporting for period 1 - CHINO (The Health Data Security Platform for EU Developers Enterprises)

Reporting period: 2017-01-01 to 2017-06-30

Digital health applications are disrupting the healthcare sector and service delivery. However, studies have shown that 85% of more than 300.000 available digital health services do not follow basic privacy and security practices.

This is a problem for:
- startups and companies developing health services who risk fines, security breaches, and their businesses,
- health organizations, insurances and pharma companies who would like to establish partnerships with developers due to lack of trust and guarantees about their compliance with laws,
- end users who are increasingly worried about privacy risks and more and more reluctant in using digital services that collect their health data.

In addition to these problems, the advent of the new EU General Data Protection Regulation (GDPR) , which defines strict rules and very high fines for personal data misuse, makes this problem increasingly relevant.

The objective and vision of Chino SRLS company is to provide services and technologies to application developers to help them to create secure and privacy law compliant applications easily. is the only Data Security Platform as a Service (PaaS) that helps digital health developers to ensure compliance with EU GDPR and US HIPAA data protection laws. Currently supports more than 30 companies in 15+ states in developing their health services and delivering them globally.

As part of the SME Instrument Phase 1 the team worked on:
- refining its value proposition by working closely with potential customers;
- strengthening its expertise on legal aspects (especially GDPR) and service offer in different EU states;
- ensuring compliance with HIPAA law and delivering its service to the US market;
- testing new channels to offer its service to hospitals, insurances and pharma companies;
- establishing partnerships with all stakeholders that are working on digital health innovation;
- growth of the team and business relationships in EU countries.

The team strategy and effort has been redirected towards the forthcoming GDPR law and US HIPAA law, and improving its offer and services to help companies to reduce risks and deliver their applications and services worldwide.
The Chino team worked on defining its innovation strategy to meet the current and future market demands on GDPR and HIPAA data protection laws.
The roadmap has been adapted, the new goals are set, and the evolution is currently in the execution phase by the team.

The project innovation target is the European and US market, helping companies to deliver their services globally without legal barriers. The main expected impact can be summarised in:
1) Better acceptance of digital health solutions among users (citizens and stakeholders);
2) Encourage Member States to widen the use of digital health though security assurance;
3) Ensure the right of patients to cross-border healthcare;
4) Support the development of EU legal and operational standards for cross-border data exchange and privacy protection;
5) Better protection against unauthorized use of personal data, breach of confidentiality and cybercrime;
and 6) Increasing the awareness of private and public stakeholders on the data security.
The Service